Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
Overview
The Danish company Novo says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
Source
Originally published at www.marketwatch.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.